QUOTE AND NEWS
Motley Fool  Jul 11  Comment 
The S&P trudges higher on the kickoff of earnings season, while small-caps American Apparel, Glu Mobile, and Achillion Pharmaceuticals lead individual stocks to the upside.
StreetInsider.com  Jul 11  Comment 
The following is a list of notable articles to help get you through the lunch hour: Microsoft (MSFT) Bolsters Azure with Latest Acquisition -> Read this! Shire plc (SHPG) Said to Meet with AbbVIe (ABBV) Following Raised Takeover Bid -> Read...
Motley Fool  Jun 30  Comment 
Achillion, Vital Therapies, and Alder Biopharmaceuticals were among biotech's biggest movers in June.
Benzinga  Jun 27  Comment 
Merck (NYSE: MRK) paid a 230 percent premium for Hepatitis C-focused Idenix Pharmaceuticals (NASDAQ: IDIX). News of the massive acquisition, earlier this month, sent shares of other Hep C companies, Enanta (NASDAQ: ENTA) and Achillion (NASDAQ:...
Benzinga  Jun 20  Comment 
Baird analyst Brian Skorney reported on “increasingly bullish” share action of Achillion Pharmaceuticals (NASDAQ: ACHN) following SEC filing by Idenix Pharmaceuticals (NASDAQ: IDIX). Skorney remarked that Achillion's stock action has been...
Benzinga  Jun 18  Comment 
Endocyte (NASDAQ: ECYT) dipped 19.95% to $6.18 in pre-market trading after the company reported that the company has regained global rights to vintafolide. La-Z-Boy (NYSE: LZB) dropped 9.22% to $22.55 in pre-market trading after the company...
Benzinga  Jun 17  Comment 
Himax Technologies (NASDAQ: HIMX) dropped 4.86% to $6.27 in pre-market trading. UBS downgraded Himax from Neutral to Sell and lowered the price target from $13.70 to $5.60. Shire plc (NASDAQ: SHPG) dipped 3.14% to $185.10 in pre-market trading....
SeekingAlpha  Jun 17  Comment 
By Adam Gefvert: Achillion (ACHN) rose 20% yesterday off of an analyst upgrade from Maxim, increasing its price target from $6 to $22 per share. This news took the spotlight from some bad news that happened for ACHN. Gilead (GILD) reported...
SeekingAlpha  Jun 16  Comment 
By Weighing Machine: Achillion (ACHN) shares have rallied an astounding 165% ($450 million increase in market value) following the news that Idenix (IDIX) would be acquired by Merck (MRK) for nearly $4 billion (a 240% premium to its share price)....
Motley Fool  Jun 16  Comment 
A trio of positive economic data send the S&P 500 modestly higher while Fusion-io, Achillion, and Covidien scorch to the upside by at least 20%.





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki